Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction. [PDF]
J Cardiovasc Dev Dis, 2023 Yang YX +10 more
europepmc +1 more source
Erhöhtes Risiko für Stentthrombosen bei DES? [PDF]
, 2018 Zusammenfassung: Im Vergleich zu unbeschichteten Stents ("bare-metal stents" [BMS]) verhindern medikamentenbeschichtete Stents ("drug-eluting stents" [DES]) mit großer Effektivität die Entstehung von Restenosen und damit die Notwendigkeit von ...
Kaiser, Christoph, Pfisterer, Matthias
core
Кардиоваскулярная терапия и профилактикаIn the last decade, the disadvantages of coronary artery (CA) drugeluting stenting have become increasingly obvious. Metallization of the artery, loss of vasoreactivity and chronic inflammation at the implantation site lead to restenosis and an increased
D. K. Vasiliev, N. A. Arablinsky
doaj +1 more source
Intrastent haematoma after treatment with a drug-eluting balloon for in-stent restenosis: a case report. [PDF]
Eur Heart J Case Rep, 2021 Hong XL, Fu GS, Li ZL, Zhang WB.
europepmc +1 more source
Clinical utility of self-expanding stents in coronary artery disease
Research Reports in Clinical Cardiology, 2015 Aditya R Boddu, Abilash R Balmuri, Masoor Kamalesh Department of Cardiology, Krannert Institute of Cardiology, Richard L Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis, IN, USA Abstract: The field of percutaneous ...
Boddu AR, Balmuri AR, Kamalesh M
doaj
A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease. [PDF]
Pharmaceutics, 2021 Lee HI +5 more
europepmc +1 more source
Drug-eluting balloon (DEB) versus plain old balloon angioplasty (POBA) in the treatment of failing dialysis access: A prospective randomized trial. [PDF]
J Int Med Res, 2022 Fransson T +4 more
europepmc +1 more source
Development of coronary stents using advanced results of materials science and technology [PDF]
, 2004 Stents are high tech endovascular implants. K&M Inc. is the single Eastern European stent producer company. The market needs more biocompatible devices as the trend of the stent development all the producers have to react.
Dobránszky, János +3 more
core
Biological Effects of Drug-Eluting Stents in the Coronary Circulation [PDF]
, 2018 Drug-eluting stents (DES) are designed to release pharmacological agents into the vessel wall in order to inhibit the response to injury causing restenosis, i.e., vascular smooth muscle cell migration and proliferation.
Steffel, Jan, Tanner, Felix
core